Comparative study of bisphenol A and its analogue bisphenol S on human hepatic cells: A focus on their potential involvement in nonalcoholic fatty liver disease

Food and Chemical Toxicology

Volumn 70, Issue , 2014, Pages 9-18

  Peyre, Ludovic ^a   Rouimi, Patrick ^a   de Sousa, Georges ^a   Héliès Toussaint, Cécile ^a   Carré, Benjamin ^a   Barcellini, Sylvie ^b   Chagnon, Marie Christine ^c   Rahmani, Roger ^a  

^a TOXALIM RESEARCH CENTRE IN FOOD TOXICOLOGY   (France)

^b CEMAGREF   (France)

^c Chu   (France)

Author keywords

Bisphenols A and S; Diethylstilbestrol; Liver; Metabolism; Pregnane X receptor; Steatosis

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; BISPHENOL S; CYTOCHROME P450 2B6; CYTOCHROME P450 3A4; DIETHYLSTILBESTROL; ESTRONE; FATTY ACID SYNTHASE; GLUTATHIONE TRANSFERASE A4; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MULTIDRUG RESISTANCE PROTEIN 1; PREGNANE X RECEPTOR; UNCLASSIFIED DRUG; ABCB1 PROTEIN, HUMAN; BENZHYDRYL DERIVATIVE; BIS(4-HYDROXYPHENYL)SULFONE; CARRIER PROTEIN; CYP2B6 PROTEIN, HUMAN; CYP3A4 PROTEIN, HUMAN; CYTOCHROME P450 3A; FASN PROTEIN, HUMAN; GLUTATHIONE TRANSFERASE; LEUKOTRIENE-C4 SYNTHASE; MULTIDRUG RESISTANCE PROTEIN; PERILIPIN 1; PHENOL DERIVATIVE; PHOSPHOPROTEIN; STEROID RECEPTOR; SULFONE;

ABCB1 GENE; ARTICLE; CHRONIC TOXICITY; CONTROLLED STUDY; CYP2B6 GENE; CYP3A4 GENE; DRUG CYTOTOXICITY; FASN GENE; GENE; GENE EXPRESSION; HEPG2 CELL LINE; HUMAN; HUMAN CELL; LIPID HOMEOSTASIS; LIPID STORAGE; LIVER CELL; LIVER TOXICITY; PLIN GENE; PROTEIN EXPRESSION; CELL LINE; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECTS; GENETICS; LIPID METABOLISM; LIVER; METABOLISM; NONALCOHOLIC FATTY LIVER; PATHOLOGY; TOXICITY;

BENZHYDRYL COMPOUNDS; CARRIER PROTEINS; CELL LINE; CYTOCHROME P-450 CYP2B6; CYTOCHROME P-450 CYP3A; FATTY ACID SYNTHASE, TYPE I; GLUTATHIONE TRANSFERASE; HEP G2 CELLS; HEPATOCYTES; HUMANS; LIPID METABOLISM; LIVER; NON-ALCOHOLIC FATTY LIVER DISEASE; P-GLYCOPROTEINS; PHENOLS; PHOSPHOPROTEINS; RECEPTORS, STEROID; SULFONES;

EID: 84900991597     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2014.04.011     Document Type: Article

References (63)

1. Aitken A.E., Lee C.M., Morgan E.T. Roles of nitric oxide in inflammatory downregulation of human cytochromes P450. Free Radic. Biol. Med. 2008, 44(6):1161-1168.
2. Andersson T.B., Kanebratt K.P., Kenna J.G. The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human. Expert Opin. Drug Metab. Toxicol. 2012, 8(7):909-920.
3. Aninat C., Piton A., Glaise D., Le Charpentier T., Langouët S., Morel F., Guguen-Guillouzo C., Guillouzo A. Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma heparg cells. Drug Metab. Dispos. 2006, 34(1):75-83.
4. ANSES, 2013. Évaluation des risques du bisphénol A pour la santé humaine. http://www.anses.fr/fr/documents/CHIM2009sa0331Ra-0.pdf.
5. Anthérieu S., Rogue A., Fromenty B., Guillouzo A., Robin M.A. Induction of vesicular steatosis by amiodarone and tetracycline is associated with up-regulation of lipogenic genes in HepaRG cells. Hepatology 2011, 53(6):1895-1905.
6. Atienzar F.A., Tilmant K., Gerets H.H., Toussaint G., Speeckaert S., Hanon E., Depelchin O., Dhalluin S. The use of real-time cell analyzer technology in drug discovery: defining optimal cell culture conditions and assay reproducibility with different adherent cellular models. J. Biomol. Screen 2011, 16(6):575-587.
7. Barrett J.R. BPA and PXR activation: human receptor is affected, mouse receptor is not. Environ. Health Perspect. 2012, 120(3):A122.
8. Besteman E.G., Zimmerman K.L., Huckle W.R., Prater M.R., Gogal R.M., Holladay S.D. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) or diethylstilbestrol (DES) cause similar hematopoietic hypocellularity and hepatocellular changes in murine fetal liver, but differentially affect gene expression. Toxicol. Pathol. 2007, 35(6):788-794.
9. Braniste V., Jouault A., Gaultier E., Polizzi A., Buisson-Brenac C., Leveque M., Martin P.G., Theodorou V., Fioramonti J., Houdeau E. Impact of oral bisphenol A at reference doses on intestinal barrier function and sex differences after perinatal exposure in rats. Proc. Natl. Acad. Sci. USA 2010, 107(1):448-453.
10. Cabaton N.J., Wadia P.R., Rubin B.S., Zalko D., Schaeberle C.M., Askenase M.H., Gadbois J.L., Tharp A.P., Whitt G.S., Sonnenschein C., et al. Perinatal exposure to environmentally relevant levels of bisphenol A decreases fertility and fecundity in CD-1 mice. Environ. Health Perspect. 2011, 119(4):547-552.
11. Chen C., Han Y.H., Yang Z., Rodrigues A.D. Effect of interferon-α2b on the expression of various drug-metabolizing enzymes and transporters in co-cultures of freshly prepared human primary hepatocytes. Xenobiotica 2011, 41(6):476-485.
12. Crépet A., Héraud F., Béchaux C., Gouze M.E., Pierlot S., Fastier A., Leblanc J.Ch., Le Hégarat L., Takakura N., Fessard V., et al. The PERICLES research program: an integrated approach to characterize the combined effects of mixtures of pesticide residues to which the French population is exposed. Toxicology 2013, 313(2-3):83-93.
13. Csanády G.A., Oberste-Frielinghaus H.R., Semder B., Baur C., Schneider K.T., Filser J.G. Distribution and unspecific protein binding of the xenoestrogens bisphenol A and daidzein. Arch. Toxicol. 2002, 76(5-6):299-305.
14. DeKeyser J.G., Laurenzana E.M., Peterson E.C., Chen T., Omiecinski C.J. Selective phthalate activation of naturally occurring human constitutive androstane receptor splice variants and the pregnane X receptor. Toxicol. Sci. 2011, 120(2):381-391.
15. Desmots F., Rissel M., Loyer P., Turlin B., Guillouzo A. Immunohistological analysis of glutathione transferase A4 distribution in several human tissues using a specific polyclonal antibody. J. Histochem. Cytochem. 2001, 49(12):1573-1580.
16. Desmots F., Rissel M., Gilot D., Lagadic-Gossmann D., Morel F., Guguen-Guillouzo C., Guillouzo A., Loyer P. Pro-inflammatory cytokines tumor necrosis factor alpha and interleukin-6 and survival factor epidermal growth factor positively regulate the murine GSTA4 enzyme in hepatocytes. J. Biol. Chem. 2002, 277(20):17892-17900.
17. Donato M.T., Lahoz A., Jiménez N., Pérez G., Serralta A., Mir J., Castell J.V., Gómez-Lechón M.J. Potential impact of steatosis on cytochrome P450 enzymes of human hepatocytes isolated from fatty liver grafts. Drug Metab. Dispos. 2006, 34(9):1556-1562.
18. Donato M.T., Martínez-Romero A., Jiménez N., Negro A., Herrera G., Castell J.V., O'Connor J.E., Gómez-Lechón M.J. Cytometric analysis for drug-induced steatosis in HepG2 cells. Chem. Biol. Interact. 2009, 181(3):417-423.
19. Dvorak Z., Modriansky M., Pichard-Garcia L., Balaguer P., Vilarem M.J., Ulrichová J., Maurel P., Pascussi J.M. Colchicine down-regulates cytochrome P450 2B6, 2C8, 2C9, and 3A4 in human hepatocytes by affecting their glucocorticoid receptor-mediated regulation. Mol. Pharmacol. 2003, 64(1):160-169.
20. Fénichel P., Déchaux H., Harthe C., Gal J., Ferrari P., Pacini P., Wagner-Mahler K., Pugeat M., Brucker-Davis F. Unconjugated bisphenol A cord blood levels in boys with descended or undescended testes. Hum. Reprod. 2012, 27(4):983-990.
21. Gerets H.H., Tilmant K., Gerin B., Chanteux H., Depelchin B.O., Dhalluin S., Atienzar F.A. Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biol. Toxicol. 2012, 28(2):69-87.
22. Greco D., Kotronen A., Westerbacka J., Puig O., Arkkila P., Kiviluoto T., Laitinen S., Kolak M., Fisher R.M., Hamsten A., et al. Gene expression in human NAFLD. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294(5):G1281-G1287.
23. Gripon P., Rumin S., Urban S., Le Seyec J., Glaise D., Cannie I., Guyomard C., Lucas J., Trepo C., Guguen-Guillouzo C. Infection of a human hepatoma cell line by hepatitis B virus. Proc. Natl. Acad. Sci. USA 2002, 99(24):15655-15660.
24. Guillouzo A., Corlu A., Aninat C., Glaise D., Morel F., Guguen-Guillouzo C. The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. Chem. Biol. Interact. 2007, 168(1):66-73.
25. Howdeshell K.L., Peterman P.H., Judy B.M., Taylor J.A., Orazio C.E., Ruhlen R.L., Vom Saal F.S., Welshons W.V. Bisphenol A is released from used polycarbonate animal cages into water at room temperature. Environ. Health Perspect. 2003, 111(9):1180-1187.
26. Huc L., Lemarié A., Guéraud F., Héliès-Toussaint C. Low concentrations of bisphenol A induce lipid accumulation mediated by the production of reactive oxygen species in the mitochondria of HepG2 cells. Toxicol. in Vitro 2012, 26(5):709-717.
27. Ibrahim S.H., Kohli R., Gores G.J. Mechanisms of lipotoxicity in NAFLD and clinical implications. J. Pediatr. Gastroenterol. Nutr. 2011, 53(2):131-140.
28. Izumi Y., Yamaguchi K., Ishikawa T., Ando M., Chiba K., Hashimoto H., Shiotani M., Fujisawa M. Molecular changes induced by bisphenol-A in rat Sertoli cell culture. Syst. Biol. Reprod. Med. 2011, 57(5):228-232.
29. Kadoma Y., Tanaka M. Acid and base-catalyzed hydrolysis of bisphenol A-related compounds. Dent. Mater. J. 2000, 19(2):139-152.
30. Khalil N., Ebert J.R., Wang L., Belcher S., Lee M., Czerwinski S.A., Kannan K. Bisphenol A and cardiometabolic risk factors in obese children. Sci. Total Environ. 2014, 470-471:726-732.
31. Kuzbari O., Peterson C.M., Franklin M.R., Hathaway L.B., Johnstone E.B., Hammoud A.O., Lamb J.G. Comparative analysis of human CYP3A4 and rat CYP3A1 induction and relevant gene expression by bisphenol A and diethylstilbestrol: implications for toxicity testing paradigms. Reprod. Toxicol. 2013, 37:24-30.
32. Lakind J.S., Goodman M., Mattison D.R. Bisphenol A and indicators of obesity, glucose metabolism/type 2 diabetes and cardiovascular disease: A systematic review of epidemiologic research. Crit. Rev. Toxicol. 2014.
33. Lang I.A., Galloway T.S., Scarlett A., Henley W.E., Depledge M., Wallace R.B., Melzer D. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 2008, 300(11):1303-1310.
34. Lemaire G., de Sousa G., Rahmani R. A PXR reporter gene assay in a stable cell culture system: CYP3A4 and CYP2B6 induction by pesticides. Biochem. Pharmacol. 2004, 68(12):2347-2358.
35. Li Y., Burns K.A., Arao Y., Luh C.J., Korach K.S. Differential estrogenic actions of endocrine-disrupting chemicals bisphenol A, bisphenol AF, and zearalenone through estrogen receptor α and β in vitro. Environ. Health Perspect. 2012, 120(7):1029-1035.
36. Liao C., Liu F., Alomirah H., Loi V.D., Mohd M.A., Moon H.B., Nakata H., Kannan K. Bisphenol S in urine from the United States and seven Asian countries: occurrence and human exposures. Environ. Sci. Technol. 2012, 46(12):6860-6866.
37. Lin Y., Sun X., Qiu L., Wei J., Huang Q., Fang C., Ye T., Kang M., Shen H., Dong S. Exposure to bisphenol A induces dysfunction of insulin secretion and apoptosis through the damage of mitochondria in rat insulinoma (INS-1) cells. Cell Death Dis. 2013, 4:e460.
38. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25(4):402-408.
39. Lu H., Gonzalez F.J., Klaassen C. Alterations in hepatic mRNA expression of phase II enzymes and xenobiotic transporters after targeted disruption of hepatocyte nuclear factor 4 alpha. Toxicol. Sci. 2010, 118(2):380-390.
40. Marmugi A., Ducheix S., Lasserre F., Polizzi A., Paris A., Priymenko N., Bertrand-Michel J., Pineau T., Guillou H., Martin P.G., et al. Low doses of bisphenol A induce gene expression related to lipid synthesis and trigger triglyceride accumulation in adult mouse liver. Hepatology 2012, 55(2):395-407.
41. Mazur C.S., Marchitti S.A., Dimova M., Kenneke J.F., Lumen A., Fisher J. Human and rat ABC transporter efflux of bisphenol a and bisphenol a glucuronide: interspecies comparison and implications for pharmacokinetic assessment. Toxicol. Sci. 2012, 128(2):317-325.
42. Molina-Molina J.M., Amaya E., Grimaldi M., Sáenz J.M., Real M., Fernández M.F., Balaguer P., Olea N. In vitro study on the agonistic and antagonistic activities of bisphenol-S and other bisphenol-A congeners and derivatives via nuclear receptors. Toxicol. Appl. Pharmacol. 2013, 272(1):127-136.
43. Moreau A., Téruel C., Beylot M., Albalea V., Tamasi V., Umbdenstock T., Parmentier Y., Sa-Cunha A., Suc B., Fabre J.M., et al. A novel pregnane X receptor and S14-mediated lipogenic pathway in human hepatocyte. Hepatology 2009, 49(6):2068-2079.
44. Moya M., Gómez-Lechón M.J., Castell J.V., Jover R. Enhanced steatosis by nuclear receptor ligands: a study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile. Chem. Biol. Interact. 2010, 184(3):376-387.
45. Nakamura S., Tezuka Y., Ushiyama A., Kawashima C., Kitagawara Y., Takahashi K., Ohta S., Mashino T. Ipso substitution of bisphenol A catalyzed by microsomal cytochrome P450 and enhancement of estrogenic activity. Toxicol. Lett. 2011, 203(1):92-95.
46. Nawaz A., Razpotnik A., Rouimi P., de Sousa G., Cravedi J.P., Rahmani R. Cellular impact of combinations of endosulfan, atrazine, and chlorpyrifos on human primary hepatocytes and HepaRG cells after short and chronic exposures. Cell Biol. Toxicol. 2013.
47. Park S.H., Kim K.Y., An B.S., Choi J.H., Jeung E.B., Leung P.C., Choi K.C. Cell growth of ovarian cancer cells is stimulated by xenoestrogens through an estrogen-dependent pathway, but their stimulation of cell growth appears not to be involved in the activation of the mitogen-activated protein kinases ERK-1 and p38. J. Reprod. Dev. 2009, 55(1):23-29.
48. Pascussi J.M., Gerbal-Chaloin S., Pichard-Garcia L., Daujat M., Fabre J.M., Maurel P., Vilarem M.J. Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes. Biochem. Biophys. Res. Commun. 2000, 274(3):707-713.
49. Pupo M., Pisano A., Lappano R., Santolla M.F., De Francesco E.M., Abonante S., Rosano C., Maggiolini M. Bisphenol a induces gene expression changes and proliferative effects through gper in breast cancer cells and cancer-associated fibroblasts. Environ. Health Perspect. 2012, 120(8):1177-1182.
50. Ryan K.K., Haller A.M., Sorrell J.E., Woods S.C., Jandacek R.J., Seeley R.J. Perinatal exposure to bisphenol-A and the development of metabolic syndrome in CD-1 mice. Endocrinology 2010, 151(6):2603-2612.
51. Santolla M.F., Lappano R., De Marco P., Pupo M., Vivacqua A., Sisci D., Abonante S., Iacopetta D., Cappello A.R., Dolce V., Maggiolini M. G protein-coupled estrogen receptor mediates the up-regulation of fatty acid synthase induced by 17β-estradiol in cancer cells and cancer-associated fibroblasts. J. Biol. Chem. 2012, 287(52):43234-43245.
52. Schönfelder G., Wittfoht W., Hopp H., Talsness C.E., Paul M., Chahoud I. Parent bisphenol A accumulation in the human maternal-fetal-placental unit. Environ. Health Perspect. 2002, 110(11):A703-A707.
53. Sengupta S., Obiorah I., Maximov P.Y., Curpan R., Jordan V.C. Molecular mechanism of action of bisphenol and bisphenol A mediated by oestrogen receptor alpha in growth and apoptosis of breast cancer cells. Brit. J. Pharmacol. 2013, 169(1):167-178.
54. Shankar A., Teppala S., Sabanayagam C. Urinary bisphenol a levels and measures of obesity: results from the national health and nutrition examination survey 2003-2008. ISRN Endocrinol. 2012, 2012:965243.
55. Somm E., Schwitzgebel V.M., Toulotte A., Cederroth C.R., Combescure C., Nef S., Aubert M.L., Hüppi P.S. Perinatal exposure to bisphenol a alters early adipogenesis in the rat. Environ. Health Perspect. 2009, 117(10):1549-1555.
56. Sui Y., Ai N., Park S.H., Rios-Pilier J., Perkins J.T., Welsh W.J., Zhou C. Bisphenol A and its analogues activate human pregnane X receptor. Environ. Health Perspect. 2012, 120(3):399-405.
57. Swedenborg E., Kotka M., Seifert M., Kanno J., Pongratz I., Rüegg J. The aryl hydrocarbon receptor ligands 2,3,7,8-tetrachlorodibenzo-p-dioxin and 3-methylcholanthrene regulate distinct genetic networks. Mol. Cell Endocrinol. 2012, 362(1-2):39-47.
58. Takeshita A., Koibuchi N., Oka J., Taguchi M., Shishiba Y., Ozawa Y. Bisphenol-A, an environmental estrogen, activates the human orphan nuclear receptor, steroid and xenobiotic receptor-mediated transcription. Eur. J. Endocrinol. 2001, 145(4):513-517.
59. Vandenberg L.N., Chahoud I., Heindel J.J., Padmanabhan V., Paumgartten F.J., Schoenfelder G. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Cien Saude Colet 2012, 17(2):407-434.
60. Viñas R., Watson C.S. Bisphenol S disrupts estradiol-induced nongenomic signaling in a rat pituitary cell line: effects on cell functions. Environ. Health Perspect. 2013, 121(3):352-358.
61. Xu X., Lu Y., Zhang G., Chen L., Tian D., Shen X., Yang Y., Dong F. Bisphenol A promotes dendritic morphogenesis of hippocampal neurons through estrogen receptor-mediated ERK1/2 signal pathway. Chemosphere 2014, 96:129-137.
62. Zhou J., Febbraio M., Wada T., Zhai Y., Kuruba R., He J., Lee J.H., Khadem S., Ren S., Li S., et al. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis. Gastroenterology 2008, 134(2):556-567.
63. Zhou C., Verma S., Blumberg B. The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism. Nucl. Recept. Signal. 2009, 7:e001.